Impact of CytoSorb Hemoadsorption Therapy on Cost-Effectiveness and Length of Stay in Critical Care Patients: A Preliminary Study from a Swiss High-Volume Center.

Healthcare (Basel) · 2026 · PMC13116302 · PMID 42073003

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

30.0 days; p = 0.008), although subgroup-specific differences did not reach statistical significance ( Figure 4 ).

also in 75,278 other papers

a favorable trendno p-value reported

While overall DRG revenue per case did not differ significantly between groups, a favorable trend toward higher reimbursement was noted in CytoSorb-treated patients with urosepsis ( Table 2 ).

also in 993 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.